Abstract
Originally, G protein-coupled receptors were assumed to act as on-off switches, adopting either an active (R*) or inactive (R) conformation. However, pharmacological and biophysical studies over the past 15–20 years have now unequivocally shown that receptors can exist in multiple active conformations with distinct capabilities to activate effectors. This concept is referred to as functional selectivity and has important implications for future drug design. Here, we discuss this fundamental pharmacological concept using the β2-adrenoceptor as paradigm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.